Nuvectis Pharma, Inc. Reports $22.3 Million Annual Loss
Company operates in the Manufacturing sector
By USInMinutes
Published - Mar 07, 2024, 07:38 AM ET
Last Updated - Mar 07, 2024, 01:15 PM EST
Nuvectis Pharma, Inc. [NVCT] has reported $22.3 Million loss for year ended Dec 31, 2023.
The company said in a filing before the Securities and Exchange Commission that its loss for the previous year was $19.08 million.